PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Tranexamic acid - Mucositis - chemotherapy / radiotherapy induced
PAD Profile : Tranexamic acid - Mucositis - chemotherapy / radiotherapy induced
Keywords :
Oropharyngeal lesions, oral ulceration, oral inflammation
Traffic Light Status
Status 1 of 2.
Status :
Red
Important
Formulations :
- Mouthwash
- Soluble tablets
Important Information :
5% mouthwash - unlicensed product. Used in line with St Luke's SACT protocols
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 2 of 2.
Guidelines
No guidelines returned.
Other Drugs
Other Indications
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
05 February 2025
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.
Associated BNF Codes
12. Ear, Nose and Oropharynx
12.03.01. Drugs for oral ulceration and inflammation